Very useful features (breast non-mass abnormalities and inflammatory bowel disease) in this issue of Journal of Medical Ultrasonics!!
Hirooka Y.
J Med Ultrason (2001). 2023 Jul;50(3):461. doi: 10.1007/s10396-023-01336-5. Epub 2023 Jul 19.
Inflammatory Breast Cancer.
Chippa V, Barazi H.
2023 Apr 16. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Idiopathic Granulomatous Mastitis.
Dilaveri C, Degnim A, Lee C, DeSimone D, Moldoveanu D, Ghosh K.
Breast J. 2024 Jan 25;2024:6693720. doi: 10.1155/2024/6693720. eCollection 2024.
[Exploring a non-inflammatory clinical breast mass: Clinical practice guidelines].
Legendre G, Guilhen N, Nadeau C, Brossard A, Fauvet R.
J Gynecol Obstet Biol Reprod (Paris). 2015 Dec;44(10):904-12. doi: 10.1016/j.jgyn.2015.09.045. Epub 2015 Nov 2.
Body mass index and risk of inflammatory breast disease: a Mendelian randomization study.
Wei C, Wang X, Zeng J, Zhang G.
Nutr Hosp. 2024 Feb 15;41(1):96-111. doi: 10.20960/nh.04746.
Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.
Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, Friedman ER, Slingerland JM.
CA Cancer J Clin. 2017 Sep;67(5):378-397. doi: 10.3322/caac.21405. Epub 2017 Aug 1.
Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study.
Iyengar NM, Arthur R, Manson JE, Chlebowski RT, Kroenke CH, Peterson L, Cheng TD, Feliciano EC, Lane D, Luo J, Nassir R, Pan K, Wassertheil-Smoller S, Kamensky V, Rohan TE, Dannenberg AJ.
JAMA Oncol. 2019 Feb 1;5(2):155-163. doi: 10.1001/jamaoncol.2018.5327.
Benign Breast Disorders.
Weaver M, Stuckey A.
Obstet Gynecol Clin North Am. 2022 Mar;49(1):57-72. doi: 10.1016/j.ogc.2021.11.003.
Inflammatory breast cancer: early recognition and diagnosis is critical.
Hester RH, Hortobagyi GN, Lim B.
Am J Obstet Gynecol. 2021 Oct;225(4):392-396. doi: 10.1016/j.ajog.2021.04.217. Epub 2021 Apr 20.
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update.
Roskoski R Jr.
Pharmacol Res. 2024 Feb;200:107059. doi: 10.1016/j.phrs.2024.107059. Epub 2024 Jan 11.
